https://www.selleckchem.com/pr....oducts/picrotoxin.ht
Background We aimed to systematically determine the impact of tumor burden on the 68Ga-prostate-specific membrane antigen-11 (68Ga-PSMA) PET biodistribution by the use of quantitative measurements. Methods This international multicenter retrospective analysis included 406 men with prostate cancer who received 68Ga-PSMA PET/CT. Of these, 356 had positive findings and were stratified by quintiles into very low (Q1, ≤25 ml), low (Q2, 25-189 ml), moderate (Q3, 189-532 ml), high (Q4, 532-1355 ml) and very high (Q5, ≥1355 ml) total PSMA-po
Like
Comment
Share
